▲ im Chart anklicken → springt zur Zeile
Breakouts 4Trefferquote 75%Ø gehalten +13.2%Median +16.6%Ø Peak +38%Ø hergegeben −25%
| Breakout | G | Entry | gehalten | Peak | hergeg. | Tage | Exit |
|---|
| 2020-08-19 | B | 29.96 | +16.6% | +36.8% | −20.3% | 22 | 2020-09-21 |
| 2023-05-17 | C | 20.25 | -0.8% | +19.4% | −20.2% | 21 | 2023-06-16 |
| 2023-09-26 | B | 25.13 | +34.5% | +75.8% | −41.3% | 19 | 2023-10-23 |
| 2026-05-20 | B | 30.16 | +2.5% | +20.3% | −17.8% | 8 | 2026-06-02 |
Regel: Einstieg am Breakout-Pivot, Trailing-Stop = Tagesschluss unter dem 20-EMA. gehalten = realisierter Gewinn bis zum Stop · Peak = max. Run-Up (MFE) · hergeg. = Peak − gehalten · „offen" = Position läuft noch.
| Jahr | Rendite | Spanne | Max-DD | Setups | Schluss |
|---|
| 2019 | +62% | 74% | -5% | | 15.87 |
| 2020 | +191% | 544% | -51% | 1 | 46.19 |
| 2021 | -82% | 653% | -86% | | 8.52 |
| 2022 | +108% | 468% | -61% | | 17.75 |
| 2023 | +137% | 219% | -28% | 2 | 42.13 |
| 2024 | -41% | 91% | -45% | | 24.77 |
| 2025 | +3% | 118% | -47% | | 25.42 |
| 2026 | +22% | 59% | -17% | 1 | 31.11 |
▲ 2020-03-18 → 2020-11-17 +530% (170 HT)
Auslöser: — (Momentum/sektorgetrieben)
▲ 2022-09-26 → 2023-01-06 +336% (71 HT)
Auslöser: — (Momentum/sektorgetrieben)
▲ 2023-04-10 → 2023-12-26 +211% (180 HT)
Auslöser: News: Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor
- 2023-07-17 +12% [News] Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study
- 2023-09-26 +97% [SEC 8-K] Material agreement, Unregistered equity sale
- 2023-12-21 +8% [SEC 8-K] Reg FD disclosure
▲ 2025-04-08 → 2026-05-20 +167% (280 HT)
Auslöser: Earnings: Earnings-Report (SEC 8-K 2.02)
- 2026-02-06 +12% [Earnings] Earnings-Report (SEC 8-K 2.02)
- 2026-05-20 +35% [Earnings] Earnings-Report (SEC 8-K 2.02)
▲ 2022-06-16 → 2022-08-25 +88% (48 HT)
Auslöser: — (Momentum/sektorgetrieben)
▲ 2019-07-12 → 2020-01-16 +78% (99 HT)
Auslöser: — (Momentum/sektorgetrieben)